Background: The rising levels of physical inactivity in the Eastern Mediterranean region (43.2%) and in the United Arab Emirates (38%) compared with the global levels of physical inactivity (31.2%) is alarming (6,15). Therefore, action is required to reduce physical inactivity using evidence-based strategies. This study aims to provide scientific evidence that if the workplace environment promotes behavior change, physical activity levels could increase and, therefore, improve health. Objective: Primary objective: to determine whether the workplace exercise intervention will improve the cardio-metabolic risk components for the employees. Secondary objective: to determine whether the workplace exercise intervention will improve physical activity levels even after 4 weeks of completing the intervention. Methods: A total of 150 participants will be recruited from a semi-government telecommunication company after meeting the eligibility criteria; 75 will be assigned to the intervention group and 75 to the delayed intervention group. Intervention: The Intervention group will receive 2 hours of exercise per week during working hours for 12 weeks. One hour can be used per day. The intervention group will be assigned to attend personal trainer sessions in the workplace gym during the intervention. After the intervention is completed the delayed intervention group will also receive 2 hours of exercise time per week from working hours for 4 weeks. Expected results: There is a statistically significant difference in the primary and secondary health outcome between the intervention group and delayed intervention group. Expected conclusion: Increasing exercise time in the workplace is associated with favorable cardio-metabolic risk profile.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from Baseline high Blood Pressure (mmHg) at 12 Weeks
Timeframe: The outcome will be measured for both groups at baseline and after the 12-week intervention.
Change from Baseline Waist Circumference (centimetres) at 12 Weeks
Timeframe: The outcome will be measured for both groups at baseline and after the 12-week intervention.
Change from Baseline HDL-cholesterol (mmol/L) at 12 Weeks
Timeframe: The outcome will be measured for both groups at baseline and after the 12-week intervention.
Change from Baseline Triglycerides (mg/dL) at 12 Weeks
Timeframe: The outcome will be measured for both groups at baseline and after the 12-week intervention.
Change from Baseline Fasting Plasma Glucose (mmol/L) at 12 Weeks
Timeframe: The outcome will be measured for both groups at baseline and after the 12-week intervention.